Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs Nucor Corporation (NUE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs Nucor Corporation — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $977.37M), while Nucor Corporation trades at $257.14 (market cap $58.33B). The key difference: Nucor Corporation is far larger — about 59.7× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and Nucor Corporation pays a 0.87% dividend while Maravai LifeSciences Holdings Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and Nucor Corporation for 78 Days on average.
| MRVI | NUE | |
|---|---|---|
Market Cap | $977.37M | $58.33B |
Volume | 2,742,564 | 1,032,707 |
Sector | Health | Basic Materials |
52-Week High | $9.00 | $274.74 |
52-Week Low | $2.83 | $131.78 |
Typical Hold Time | 0 Days | 78 Days |
Enterprise Value | $1.08B | $62.74B |
Dividend Yield | — | 0.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
Nucor (NUE) trades at $253.80, up 0.78% on the day, with a bullish technical signal driven by moving averages and near-term resistance at $254. The stock has shown strong earnings momentum, beating estimates in two of the last three quarters, with Q3 2026 guidance projecting higher earnings. Revenue trends are improving, with 2026 revenue forecast at $36.1B, and the company maintains a solid balance sheet with a debt-to-asset ratio of 20.23% as of 2025. Analyst consensus is a 'Buy' with a $266.88 price target, reflecting optimism around steel pricing and operational execution.
The outlook for NUE is positive, supported by earnings beats, favorable steel market dynamics, and a shareholder-friendly dividend policy. Key risks include competitive pressures from new capacity, volatility in steel prices, and macroeconomic sensitivity. The stock offers upside to consensus targets but requires monitoring of cost pressures and industry supply changes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About Nucor Corporation
Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products and raw materials, the steel mills segment derives maximum revenue.
Read more on NUE →
